Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges

NCT04477304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 555

Last updated 2025-08-07

Study results available
· View outcomes & findings →

Summary

The opioid epidemic has had a tremendous negative impact on the health of persons in the U.S. The objective of the trial 1 of Application of Economics \& Social psychology to improve Opioid Prescribing Safety (AESOPS-T1), is to discourage unnecessary opioid prescribing through the application of "behavioral insights"-empirically-tested social and psychological interventions that affect choice.

Conditions

  • Opioid Abuse, Unspecified

Interventions

BEHAVIORAL

Opioid Naive, OR

Visits where the order is for an included opioid and there is no prior opioid prescription with a start date of greater than 1 day and less than 91 days and clinician is on the clinic list as a treating member of the clinic

BEHAVIORAL

At-risk for long-term use, OR

Visit where the order is for an included opioid, there is a prior opioid prescription with a start date greater than 1 day and less than 91 days, and there is no prior opioid prescription with a start date greater than 90 days and clinician is on the clinic list as a treating member of the clinic

BEHAVIORAL

Long-term opioid recipient

Total opioid doses are at least 50 MME per day, there are two or more prior opioid prescriptions with two different start dates both greater than 1 day and less than 91 days, and there is a prior opioid prescription with a start date greater than 90 days and less than 181 days and clinician is on the clinic list as a treating member of the clinic

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER
  • AltaMed Health Services Corporation

    collaborator OTHER
  • National Institute on Aging (NIA)

    collaborator NIH
  • University of Southern California

    lead OTHER

Principal Investigators

  • Jason N Doctor, PhD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-08-06
Completion
2023-08-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477304 on ClinicalTrials.gov